Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (257)
NICE advice (26)
Quality standard (13)
Guidance programme
Guidance programme
Cancer service guidelines (5)
Clinical guidelines (17)
Diagnostics guidance (11)
Health technology evaluations (1)
Interventional procedures guidance (44)
Medical technologies guidance (3)
NICE guidelines (23)
Public health guidelines (1)
Social care guidelines (2)
Technology appraisal guidance (175)
Apply filters
Showing 21 to 30 of 257
Sort by
Date
Title
Apply sorting
cancer
Remove cancer filter
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Quantitative faecal immunochemical testing to guide colorectal
cancer
pathway referral in primary care
DG56
24 August 2023
24 August 2023
Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung
cancer
TA911
26 July 2023
26 July 2023
Lorlatinib for untreated ALK-positive advanced non-small-cell lung
cancer
TA909
12 July 2023
12 July 2023
Irreversible electroporation for treating prostate
cancer
IPG768
5 July 2023
5 July 2023
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal
cancer
after 2 or more courses of platinum-based chemotherapy
TA908
5 July 2023
5 July 2023
Oesophago-gastric
cancer
: assessment and management in adults
NG83
24 January 2018
4 July 2023
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate
cancer
TA903
21 June 2023
21 June 2023
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial
cancer
TA904
21 June 2023
21 June 2023
Cemiplimab for treating recurrent or metastatic cervical
cancer
(terminated appraisal)
TA901
20 June 2023
20 June 2023
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung
cancer
TA898
14 June 2023
14 June 2023
Previous page
1
2
Current page
3
4
5
…
26
Page
3
of
26
Next page
Results per page
10
25
50
All
Back to top